Related Experiment Video
Updated: Jun 22, 2026
17:16
Registered Bioimaging of Nanomaterials for Diagnostic and Therapeutic Monitoring
Published on: December 9, 2010
Genomic biomarkers for molecular imaging: predicting the future.
1Laboratories of Radiopharmaceutical Research and Molecular Imaging, Department of Radiology and Radiation Oncology, Thomas Jefferson University, Philadelphia, PA 19107, USA. Mathew.Thakur@jefferson.edu
Seminars in Nuclear Medicine
|June 6, 2009
Summary
Novel molecular imaging probes target cancer biomarkers for early detection. This approach enhances diagnosis of occult lesions missed by current methods, improving cancer management.
Area of Science:
- Oncology
- Molecular Imaging
- Biochemistry
Background:
- Despite advances in anatomical imaging, cancer remains a leading cause of death.
- Molecular abnormalities and specific biomarkers are key to cancer development.
- Current diagnostic methods have limitations in detecting early-stage disease.
Purpose of the Study:
- To explore novel molecular imaging probes for cancer diagnosis.
- To demonstrate the utility of targeting specific cancer biomarkers.
- To improve early detection of occult cancer lesions.
Main Methods:
- Design and synthesis of novel molecular probes.
- Evaluation of probes for Positron Emission Tomography (PET) and Single-Photon Emission Computed Tomography (SPECT) imaging.
- Targeting of oncogenes and their protein products as biomarkers.
Main Results:
- Developed and evaluated novel probes specific to cancer biomarkers.
- Demonstrated molecular imaging's ability to detect occult lesions.
- Showcased potential for improved cancer diagnosis and therapy.
Conclusions:
- Molecular imaging targeting specific biomarkers offers a promising approach for early cancer detection.
- This technique can identify lesions undetectable by conventional scintigraphy.
- Future applications may expand the use of targeted molecular probes in oncology.
Related Concept Videos
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
02:11Reporter Genes
Reporter genes are a type of protein-coding gene that are often tagged to a gene of interest. Once inside a target cell, reporter genes usually produce visually identifiable characteristics like fluorescence and luminescence when expressed along with the gene of interest. Thus, reporter genes “report” the presence or absence of genes of interest in an organism, determine the gene expression pattern, or track the physical location of a DNA segment or protein in the cell.
Commonly used reporter...
Commonly used reporter...
02:02Genomics
Genomics is the science of genomes: it is the study of all the genetic material of an organism. In humans, the genome consists of information carried in 23 pairs of chromosomes in the nucleus, as well as mitochondrial DNA. In genomics, both coding and non-coding DNA is sequenced and analyzed. Genomics allows a better understanding of all living things, their evolution, and their diversity. It has a myriad of uses: for example, to build phylogenetic trees, to improve productivity and...